USPTO-FDA Listening Session — Voices from Patient and Patent Advocates | Foley & Lardner LLP
On January 19, 2023, the U.S. Patent and Trademark Office (USPTO) and Food and Drug Administration (FDA) held a “listening session” focusing on USPTO-FDA collaboration initiatives...